Effect of rituximab given along with dose-adjusted EPOCH in patients with Burkitt Lymphoma, T-Cell Lymphoma and Large B-Cell Lymphoma

Trial Profile

Effect of rituximab given along with dose-adjusted EPOCH in patients with Burkitt Lymphoma, T-Cell Lymphoma and Large B-Cell Lymphoma

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Apr 2015

At a glance

  • Drugs Rituximab (Primary) ; Cyclophosphamide; Doxorubicin; Etoposide; Prednisolone; Vincristine
  • Indications Burkitt's lymphoma; Diffuse large B cell lymphoma; T cell lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top